The healthcare it outsourcing industry is expected to reach over US$ 105.753 billion by 2033, developing at a healthy CAGR of 7.2%. Revenue of US$ 52.877 billion is anticipated for the healthcare IT outsourcing market in 2023. The healthcare it outsourcing market has witnessed significant growth in recent years, driven by the increasing adoption of …
Category Archives: Healthcare Trends
Global Glucose Sensor Market Projects Phenomenal Growth: Anticipated Surge to Reach US$ 16,382 Million by 2032
The global glucose sensor market is set to experience remarkable growth, according to a recent market analysis. By the end of 2022, the market is expected to generate approximately US$ 7,588 million in revenue. Moreover, forecasts predict an impressive Compound Annual Growth Rate (CAGR) of 8.6% from 2022 to 2032, with the market estimated to …
Global Cell-Free Fetal DNA Testing Market, as projected by FMI, is set to experience a 10.9% CAGR by 2033, fueling advancements in prenatal screening
The cell-free fetal dna testing market is expected to have a CAGR of 10.9%. By 2023, the market is anticipated to be worth US$ 1,466.3 million, and by 2033, it’s anticipated to be worth US$ 4,124.7 million. The cell-free fetal dna testing market refers to the market for non-invasive prenatal tests (NIPT) that analyze cell-free …
Global Companion Diagnostics Market, identified as pivotal in Personalized Medicine, is projected by FMI to realize US$ 10,560.0 Million in sales by 2033
The global companion diagnostics market is expected to generate US$ 10560.0 million in sales by 2033, up from US$ 5371.9 million in 2023. During the forecast period, the companion diagnostics industry may blossom at a CAGR of 7.0%. A rapidly expanding area of personalised medicine is the companion diagnostics market. Companion diagnostics are medical tests that …
Global Endoscopic Closure Systems Industry Segment is poised for a stable 6.3% CAGR from 2023 to 2033
The global endoscopic closure systems industry sales are expected to be valued at US$ 309.2 million in 2023, exhibiting a CAGR of 6.3% at US$ 570.2 million from 2023 to 2033. The endoscopic closure systems industry expanded at a CAGR of 4.1% from 2018 to 2022. Growing demand for endoscopy to identify and treat target …
Global Electric Acupuncture Devices Industry, With Healthcare Professionals at the Helm, Anticipates a 7.1% CAGR from 2023 to 2033, Signaling Prosperity | FMI
The global electric acupuncture devices industry is projected to be worth US$ 13.9 million in 2023 and US$ 27.5 million from 2023 to 2033, capturing a CAGR of 7.1%. The electric acupuncture devices industry is anticipated to expand significantly in the upcoming years due to rising demand for non-invasive treatments and rising public awareness of …
Global Endoscopic Vessel Harvesting System Industry Set to Reach US$ 746.1 Million by 2033, Reveals Latest Projections
The Global Endoscopic Vessel Harvesting System Industry is poised for substantial growth, with a projected size of US$ 746.1 million by 2033, representing a robust CAGR of 3.7%. This forecast, unveiled today, highlights the market’s upward trajectory from its current valuation of US$ 520.4 million in 2023. The growing prevalence of cardiovascular disease is driving …
Global Exonucleases Industry Set to Soar with a 2.3% CAGR, Projected Worth of US$ 208.1 Million by 2032 | Insights by FMI
The Global Exonucleases Industry is anticipated to experience a CAGR of 2.3% over the course of the forecast period. The market is anticipated to be worth US$ 162.6 million in 2022 and US$ 208.1 million by 2032. Endonuclease is one of the type of nucleases which cut off nucleic acids from the middle. Exonucleases are …
Global Equine Veterinary Therapeutics Industry Set to Surge with a 6.8% CAGR, Projected to Reach US$ 2,671.9 Million by 2033 | Insights by FMI
From US$ 1,378.7 million in 2023, the worldwide Global Equine Veterinary Therapeutics Industry is anticipated to grow significantly and reach US$ 2,671.9 million in revenue by 2033. This revenue growth is made possible by an exceptional CAGR of 6.8%. Equine veterinary therapeutics is the branch of equine healthcare that deals with the prevention and treatment of several …
Global Insulin Biosimilars Industry Poised to Surpass US$ 2 Billion by 2033, at a CAGR of 3.4% | FMI
The Global Insulin Biosimilars Industry is on a trajectory of remarkable growth, with a projected worth of US$ 1,507.7 million in 2023 set to surge to over US$ 2,096.5 million by 2033. This surge is fueled by a robust adoption rate, with insulin biosimilars, alongside other insulin pharmaceutical products, anticipated to exhibit a Compound Annual …